Committee
This Symposium has Concluded
Co-Chairs
A.L. Burlingame
Department of Pharmaceutical Chemistry
University of California, San Francisco, CA, USA
John T. Stults
Genentech, Inc.
South San Francisco, CA, USA
Ruedi H. Aebersold
Swiss Federal Institute of Technology, Zürich, Switzerland
and Institute for Systems Biology, Seattle, WA, USA
Simon J. Gaskell
The University of Manchester
Michael Barber Center for MS
Manchester, United Kingdom
Conference Coordinator
Nancy Wang
Mass Spectrometry Facility
Department of Pharmaceutical Chemistry
University of California, San Francisco, CA, USA 94143-0446
+1 (415) 476-2582
Organizing Committee
| Thomas A. Baillie | Merck Research Laboratories, West Point, PA, USA |
| John J.M. Bergeron | McGill University, Montreal, Canada |
| Ralph A. Bradshaw | University of California, San Francisco, CA, USA |
| Steven A. Carr | Broad Institute, Cambridge, MA, USA |
| Catherine E. Costello | Boston University, Boston, MA, USA |
| Raymond J. Deshaies | California Institute of Technology, Pasadena, CA, USA |
| Emilio Gelpi | Institute for Biomedical Investigation (IIBB-CSIC), Barcelona, Spain |
| Michael L. Gross | Washington University, St. Louis, MO, USA |
| Karl-Anders Karlsson | Gothenburg University, Gothenburg, Sweden |
| Gennaro Marino | University of Naples, Naples, Italy |
| Robert C. Murphy | University of Colorado Health Sciences Center, Aurora, CO, USA |
| Scott D. Patterson | Amgen, Thousand Oaks, CA, USA |
| Jasna Peter-Katalinic | University of Münster, Münster, Germany |
| Peter Roepstorff | University of Southern Denmark, Odense, Denmark |
| Jan Sjövall | Karolinska Institute, Stockholm, Sweden |
